An upregulation of ACE-2, a receptor for SARS-CoV-2 entry, into the host epithelial cells of COPD patient’s airways could be one of the main reasons (Leung et al., 2020; Milne et al., 2020). The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.